HilleVax, Inc. (HLVX)
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
Address
321 HARRISON AVE, SUITE 500
BOSTON, MA 02118
Founded
2020
Number of Employees
90
Website
http://www.hillevax.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at HLVX make a trade.
Creating a free account takes less than one minute